The LOOK-UP is an investigator-initiated clinical study with the aim of monitoring the post-marketing safety of the medicine Rinvoq™ (upadacitinib), which is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, atopic dermatitis, ulcerative colitis, and Crohn's disease. The Marketing Authorisation Holder is AbbVie Deutschland GmbH \& Co. KG.
Prescription of Rinvoq™ from January 1, 2024;
18 years of age or older at the time of recruitment; and
Expressed consent to participate in the study.
They have any degree of cognitive impairment that prevents them from responding to a questionnaire administered by telephone;
They are participating in a phase I, II, or III clinical trial;
They have a life expectancy of less than 1 month; or
They do not have a valid telephone contact.
Universidade do Porto
Lead sponsor
INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, I.P.
Collaborator
Unidade de Farmacovigilância do Porto
Collaborator
Unidade Local de Saúde São João
Collaborator
Unidade Local de Saúde de Santo António, E.P.E.
Collaborator
Unidade Local de Saude de Gaia e Espinho EPE
Collaborator
RISE Health
Collaborator